questionsmedicales.fr
Enzymes et coenzymes
Enzymes
Oxidoreductases
Oxygénases
Mixed function oxygenases
Mixed function oxygenases : Questions médicales fréquentes
Termes MeSH sélectionnés :
Molecular Docking Simulation
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Mixed function oxygenases : Questions médicales les plus fréquentes",
"headline": "Mixed function oxygenases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Mixed function oxygenases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-08",
"dateModified": "2025-04-04",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Mixed function oxygenases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Oxygénases",
"url": "https://questionsmedicales.fr/mesh/D010105",
"about": {
"@type": "MedicalCondition",
"name": "Oxygénases",
"code": {
"@type": "MedicalCode",
"code": "D010105",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Benzoate 4-monooxygenase",
"alternateName": "Benzoate 4-Monooxygenase",
"url": "https://questionsmedicales.fr/mesh/D050565",
"about": {
"@type": "MedicalCondition",
"name": "Benzoate 4-monooxygenase",
"code": {
"@type": "MedicalCode",
"code": "D050565",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.062"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Catechol oxidase",
"alternateName": "Catechol Oxidase",
"url": "https://questionsmedicales.fr/mesh/D004156",
"about": {
"@type": "MedicalCondition",
"name": "Catechol oxidase",
"code": {
"@type": "MedicalCode",
"code": "D004156",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.125"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Monophenol monooxygenase",
"alternateName": "Monophenol Monooxygenase",
"url": "https://questionsmedicales.fr/mesh/D014442",
"about": {
"@type": "MedicalCondition",
"name": "Monophenol monooxygenase",
"code": {
"@type": "MedicalCode",
"code": "D014442",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.125.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "7-Alkoxycoumarin O-dealkylase",
"alternateName": "7-Alkoxycoumarin O-Dealkylase",
"url": "https://questionsmedicales.fr/mesh/D015660",
"about": {
"@type": "MedicalCondition",
"name": "7-Alkoxycoumarin O-dealkylase",
"code": {
"@type": "MedicalCode",
"code": "D015660",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.170.010.024"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dopamine beta-monooxygenase",
"alternateName": "Dopamine beta-Hydroxylase",
"url": "https://questionsmedicales.fr/mesh/D004299",
"about": {
"@type": "MedicalCondition",
"name": "Dopamine beta-monooxygenase",
"code": {
"@type": "MedicalCode",
"code": "D004299",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.292"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Fatty acid desaturases",
"alternateName": "Fatty Acid Desaturases",
"url": "https://questionsmedicales.fr/mesh/D044943",
"about": {
"@type": "MedicalCondition",
"name": "Fatty acid desaturases",
"code": {
"@type": "MedicalCode",
"code": "D044943",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.392"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "beta-Carotene 15,15'-monooxygenase",
"alternateName": "beta-Carotene 15,15'-Monooxygenase",
"url": "https://questionsmedicales.fr/mesh/D050559",
"about": {
"@type": "MedicalCondition",
"name": "beta-Carotene 15,15'-monooxygenase",
"code": {
"@type": "MedicalCode",
"code": "D050559",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.392.312"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Delta-5 fatty acid desaturase",
"alternateName": "Delta-5 Fatty Acid Desaturase",
"url": "https://questionsmedicales.fr/mesh/D000090943",
"about": {
"@type": "MedicalCondition",
"name": "Delta-5 fatty acid desaturase",
"code": {
"@type": "MedicalCode",
"code": "D000090943",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.392.390"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Linoleoyl-CoA desaturase",
"alternateName": "Linoleoyl-CoA Desaturase",
"url": "https://questionsmedicales.fr/mesh/D050602",
"about": {
"@type": "MedicalCondition",
"name": "Linoleoyl-CoA desaturase",
"code": {
"@type": "MedicalCode",
"code": "D050602",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.392.468"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Acyl-(acyl-carrier-protein)desaturase",
"alternateName": "Stearoyl-CoA Desaturase",
"url": "https://questionsmedicales.fr/mesh/D013230",
"about": {
"@type": "MedicalCondition",
"name": "Acyl-(acyl-carrier-protein)desaturase",
"code": {
"@type": "MedicalCode",
"code": "D013230",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.392.625"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "gamma-butyrobetaine dioxygenase",
"alternateName": "gamma-Butyrobetaine Dioxygenase",
"url": "https://questionsmedicales.fr/mesh/D050563",
"about": {
"@type": "MedicalCondition",
"name": "gamma-butyrobetaine dioxygenase",
"code": {
"@type": "MedicalCode",
"code": "D050563",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.401"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Heme oxygenase (decyclizing)",
"alternateName": "Heme Oxygenase (Decyclizing)",
"url": "https://questionsmedicales.fr/mesh/D006419",
"about": {
"@type": "MedicalCondition",
"name": "Heme oxygenase (decyclizing)",
"code": {
"@type": "MedicalCode",
"code": "D006419",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.410"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Heme oxygenase-1",
"alternateName": "Heme Oxygenase-1",
"url": "https://questionsmedicales.fr/mesh/D051547",
"about": {
"@type": "MedicalCondition",
"name": "Heme oxygenase-1",
"code": {
"@type": "MedicalCode",
"code": "D051547",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.410.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "4-Hydroxybenzoate 3-monooxygenase",
"alternateName": "4-Hydroxybenzoate-3-Monooxygenase",
"url": "https://questionsmedicales.fr/mesh/D015109",
"about": {
"@type": "MedicalCondition",
"name": "4-Hydroxybenzoate 3-monooxygenase",
"code": {
"@type": "MedicalCode",
"code": "D015109",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.425"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Kynurenine 3-monooxygenase",
"alternateName": "Kynurenine 3-Monooxygenase",
"url": "https://questionsmedicales.fr/mesh/D050601",
"about": {
"@type": "MedicalCondition",
"name": "Kynurenine 3-monooxygenase",
"code": {
"@type": "MedicalCode",
"code": "D050601",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.557"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Phenylalanine 4-monooxygenase",
"alternateName": "Phenylalanine Hydroxylase",
"url": "https://questionsmedicales.fr/mesh/D010651",
"about": {
"@type": "MedicalCondition",
"name": "Phenylalanine 4-monooxygenase",
"code": {
"@type": "MedicalCode",
"code": "D010651",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.601"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Procollagen-lysine, 2-oxoglutarate 5-dioxygenase",
"alternateName": "Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase",
"url": "https://questionsmedicales.fr/mesh/D008240",
"about": {
"@type": "MedicalCondition",
"name": "Procollagen-lysine, 2-oxoglutarate 5-dioxygenase",
"code": {
"@type": "MedicalCode",
"code": "D008240",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.660"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Prolyl hydroxylases",
"alternateName": "Prolyl Hydroxylases",
"url": "https://questionsmedicales.fr/mesh/D064828",
"about": {
"@type": "MedicalCondition",
"name": "Prolyl hydroxylases",
"code": {
"@type": "MedicalCode",
"code": "D064828",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.694"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hypoxia-inducible factor-proline dioxygenases",
"alternateName": "Hypoxia-Inducible Factor-Proline Dioxygenases",
"url": "https://questionsmedicales.fr/mesh/D064799",
"about": {
"@type": "MedicalCondition",
"name": "Hypoxia-inducible factor-proline dioxygenases",
"code": {
"@type": "MedicalCode",
"code": "D064799",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.694.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Procollagen-Proline Dioxygenase",
"alternateName": "Procollagen-Proline Dioxygenase",
"url": "https://questionsmedicales.fr/mesh/D011393",
"about": {
"@type": "MedicalCondition",
"name": "Procollagen-Proline Dioxygenase",
"code": {
"@type": "MedicalCode",
"code": "D011393",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.694.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Prostaglandin-endoperoxide synthases",
"alternateName": "Prostaglandin-Endoperoxide Synthases",
"url": "https://questionsmedicales.fr/mesh/D011451",
"about": {
"@type": "MedicalCondition",
"name": "Prostaglandin-endoperoxide synthases",
"code": {
"@type": "MedicalCode",
"code": "D011451",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.715"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Squalene monooxygenase",
"alternateName": "Squalene Monooxygenase",
"url": "https://questionsmedicales.fr/mesh/D050603",
"about": {
"@type": "MedicalCondition",
"name": "Squalene monooxygenase",
"code": {
"@type": "MedicalCode",
"code": "D050603",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.749"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Trans-cinnamate 4-monooxygenase",
"alternateName": "Trans-Cinnamate 4-Monooxygenase",
"url": "https://questionsmedicales.fr/mesh/D050564",
"about": {
"@type": "MedicalCondition",
"name": "Trans-cinnamate 4-monooxygenase",
"code": {
"@type": "MedicalCode",
"code": "D050564",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.826"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tryptophane 5-monooxygenase",
"alternateName": "Tryptophan Hydroxylase",
"url": "https://questionsmedicales.fr/mesh/D014365",
"about": {
"@type": "MedicalCondition",
"name": "Tryptophane 5-monooxygenase",
"code": {
"@type": "MedicalCode",
"code": "D014365",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.870"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vitamin K epoxide reductases",
"alternateName": "Vitamin K Epoxide Reductases",
"url": "https://questionsmedicales.fr/mesh/D064417",
"about": {
"@type": "MedicalCondition",
"name": "Vitamin K epoxide reductases",
"code": {
"@type": "MedicalCode",
"code": "D064417",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.708.961"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Mixed function oxygenases",
"alternateName": "Mixed Function Oxygenases",
"code": {
"@type": "MedicalCode",
"code": "D006899",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Shuyue Wang",
"url": "https://questionsmedicales.fr/author/Shuyue%20Wang",
"affiliation": {
"@type": "Organization",
"name": "MOE Key Laboratory of Molecular Genetics and Breeding, College of Marine Life Sciences, Ocean University of China, Qingdao 266003, China."
}
},
{
"@type": "Person",
"name": "Liang Zhao",
"url": "https://questionsmedicales.fr/author/Liang%20Zhao",
"affiliation": {
"@type": "Organization",
"name": "MOE Key Laboratory of Molecular Genetics and Breeding, College of Marine Life Sciences, Ocean University of China, Qingdao 266003, China."
}
},
{
"@type": "Person",
"name": "Tingting Li",
"url": "https://questionsmedicales.fr/author/Tingting%20Li",
"affiliation": {
"@type": "Organization",
"name": "MOE Key Laboratory of Molecular Genetics and Breeding, College of Marine Life Sciences, Ocean University of China, Qingdao 266003, China."
}
},
{
"@type": "Person",
"name": "Huizhen Wang",
"url": "https://questionsmedicales.fr/author/Huizhen%20Wang",
"affiliation": {
"@type": "Organization",
"name": "MOE Key Laboratory of Molecular Genetics and Breeding, College of Marine Life Sciences, Ocean University of China, Qingdao 266003, China."
}
},
{
"@type": "Person",
"name": "Zhenmin Bao",
"url": "https://questionsmedicales.fr/author/Zhenmin%20Bao",
"affiliation": {
"@type": "Organization",
"name": "MOE Key Laboratory of Molecular Genetics and Breeding, College of Marine Life Sciences, Ocean University of China, Qingdao 266003, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Molecular docking, simulation and binding free energy analysis of small molecules as PfHT1 inhibitors.",
"datePublished": "2022-08-26",
"url": "https://questionsmedicales.fr/article/36026508",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0268269"
}
},
{
"@type": "ScholarlyArticle",
"name": "Py-CoMFA, docking, and molecular dynamics simulations of Leishmania (L.) amazonensis arginase inhibitors.",
"datePublished": "2024-05-21",
"url": "https://questionsmedicales.fr/article/38773273",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-62520-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Exploring the molecular mechanism of ginseng against anthracycline-induced cardiotoxicity based on network pharmacology, molecular docking and molecular dynamics simulation.",
"datePublished": "2024-09-06",
"url": "https://questionsmedicales.fr/article/39243097",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s41065-024-00334-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Study of the antidiabetic mechanism of berberine compound on FOXO1 transcription factor through molecular docking and molecular dynamics simulations.",
"datePublished": "2024-07-09",
"url": "https://questionsmedicales.fr/article/38981921",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00894-024-06060-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Research advances of molecular docking and molecular dynamic simulation in recognizing interaction between muscle proteins and exogenous additives.",
"datePublished": "2023-07-08",
"url": "https://questionsmedicales.fr/article/37453331",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.foodchem.2023.136836"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Enzymes et coenzymes",
"item": "https://questionsmedicales.fr/mesh/D045762"
},
{
"@type": "ListItem",
"position": 3,
"name": "Enzymes",
"item": "https://questionsmedicales.fr/mesh/D004798"
},
{
"@type": "ListItem",
"position": 4,
"name": "Oxidoreductases",
"item": "https://questionsmedicales.fr/mesh/D010088"
},
{
"@type": "ListItem",
"position": 5,
"name": "Oxygénases",
"item": "https://questionsmedicales.fr/mesh/D010105"
},
{
"@type": "ListItem",
"position": 6,
"name": "Mixed function oxygenases",
"item": "https://questionsmedicales.fr/mesh/D006899"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Mixed function oxygenases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Mixed function oxygenases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-05",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Mixed function oxygenases",
"description": "Comment diagnostiquer une dysfonction des oxydases à fonction mixte ?\nQuels tests sont utilisés pour évaluer l'activité des oxydases ?\nLes tests génétiques sont-ils utiles pour ces enzymes ?\nQuels symptômes peuvent indiquer une anomalie enzymatique ?\nComment les antécédents médicaux aident-ils au diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D006899?mesh_terms=Molecular+Docking+Simulation&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Mixed function oxygenases",
"description": "Quels sont les symptômes d'une déficience en oxydases ?\nPeut-on observer des symptômes neurologiques ?\nLes symptômes varient-ils selon les individus ?\nQuels signes cliniques sont associés à une suractivité enzymatique ?\nLes symptômes peuvent-ils être confondus avec d'autres maladies ?",
"url": "https://questionsmedicales.fr/mesh/D006899?mesh_terms=Molecular+Docking+Simulation&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Mixed function oxygenases",
"description": "Comment prévenir les dysfonctionnements des oxydases ?\nL'éducation des patients est-elle importante ?\nLes bilans de santé réguliers aident-ils ?\nLes habitudes alimentaires influencent-elles la fonction enzymatique ?\nLes vaccinations ont-elles un impact sur la fonction enzymatique ?",
"url": "https://questionsmedicales.fr/mesh/D006899?mesh_terms=Molecular+Docking+Simulation&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Mixed function oxygenases",
"description": "Quels traitements sont disponibles pour les dysfonctionnements enzymatiques ?\nLes suppléments peuvent-ils aider à la fonction enzymatique ?\nComment la pharmacogénétique influence-t-elle le traitement ?\nLes traitements sont-ils différents pour les enfants et les adultes ?\nDes thérapies géniques sont-elles envisagées ?",
"url": "https://questionsmedicales.fr/mesh/D006899?mesh_terms=Molecular+Docking+Simulation&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Mixed function oxygenases",
"description": "Quelles complications peuvent survenir avec une dysfonction enzymatique ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications sont-elles plus fréquentes chez certains groupes ?\nLes complications peuvent-elles être prévenues ?",
"url": "https://questionsmedicales.fr/mesh/D006899?mesh_terms=Molecular+Docking+Simulation&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Mixed function oxygenases",
"description": "Quels sont les principaux facteurs de risque pour les dysfonctionnements enzymatiques ?\nL'âge influence-t-il le risque de dysfonctionnement ?\nLes maladies chroniques augmentent-elles le risque ?\nLe mode de vie joue-t-il un rôle dans le risque ?\nLes interactions médicamenteuses sont-elles un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D006899?mesh_terms=Molecular+Docking+Simulation&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction des oxydases à fonction mixte ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests enzymatiques et l'analyse des métabolites dans le sang."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'activité des oxydases ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de métabolisme des médicaments et des analyses biochimiques sont utilisés."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles pour ces enzymes ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques peuvent identifier des mutations affectant l'activité enzymatique."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une anomalie enzymatique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la toxicité médicamenteuse ou des réactions indésirables peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment les antécédents médicaux aident-ils au diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents d'exposition à des médicaments ou toxines peuvent orienter le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une déficience en oxydases ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des réactions médicamenteuses imprévues et une toxicité accrue."
}
},
{
"@type": "Question",
"name": "Peut-on observer des symptômes neurologiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes neurologiques peuvent survenir en raison d'une accumulation de toxines."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon les individus ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la gravité et le type de symptômes peuvent varier selon la génétique et l'environnement."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont associés à une suractivité enzymatique ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une suractivité peut entraîner une dégradation rapide des médicaments et des effets secondaires."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils être confondus avec d'autres maladies ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent ressembler à ceux d'autres maladies métaboliques ou hépatiques."
}
},
{
"@type": "Question",
"name": "Comment prévenir les dysfonctionnements des oxydases ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter l'exposition à des médicaments et toxines connus pour affecter ces enzymes."
}
},
{
"@type": "Question",
"name": "L'éducation des patients est-elle importante ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, informer les patients sur les risques liés aux médicaments est essentiel pour la prévention."
}
},
{
"@type": "Question",
"name": "Les bilans de santé réguliers aident-ils ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des bilans réguliers peuvent détecter précocement des anomalies enzymatiques."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles la fonction enzymatique ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée peut soutenir la santé enzymatique et métabolique."
}
},
{
"@type": "Question",
"name": "Les vaccinations ont-elles un impact sur la fonction enzymatique ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations peuvent influencer le métabolisme, mais les effets varient."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les dysfonctionnements enzymatiques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des ajustements médicamenteux et des thérapies de soutien."
}
},
{
"@type": "Question",
"name": "Les suppléments peuvent-ils aider à la fonction enzymatique ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains suppléments peuvent améliorer la fonction enzymatique, selon le cas."
}
},
{
"@type": "Question",
"name": "Comment la pharmacogénétique influence-t-elle le traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La pharmacogénétique permet de personnaliser les traitements en fonction du profil enzymatique."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils différents pour les enfants et les adultes ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les dosages et les choix de médicaments peuvent varier entre enfants et adultes."
}
},
{
"@type": "Question",
"name": "Des thérapies géniques sont-elles envisagées ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des recherches sont en cours sur les thérapies géniques pour corriger les déficiences enzymatiques."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une dysfonction enzymatique ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des réactions médicamenteuses graves et des maladies hépatiques."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié, d'autres non."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent réduire la qualité de vie en limitant les options de traitement."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles plus fréquentes chez certains groupes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines populations peuvent être plus à risque en raison de facteurs génétiques."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être prévenues ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être évitées par une surveillance et un traitement précoce."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque pour les dysfonctionnements enzymatiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, l'exposition à des toxines et certains médicaments."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de dysfonctionnement ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque peut augmenter avec l'âge en raison de changements métaboliques."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies chroniques peuvent affecter la fonction enzymatique et augmenter le risque."
}
},
{
"@type": "Question",
"name": "Le mode de vie joue-t-il un rôle dans le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie malsain, comme une mauvaise alimentation, peut augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les interactions médicamenteuses sont-elles un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines interactions médicamenteuses peuvent altérer l'activité des oxydases à fonction mixte."
}
}
]
}
]
}
Antimalarial drug resistance has thrown a spanner in the works of malaria elimination. New drugs are required for ancillary support of existing malaria control efforts. Plasmodium falciparum requires ...
Leishmaniasis is a disease caused by a protozoan of the genus Leishmania, affecting millions of people, mainly in tropical countries, due to poor social conditions and low economic development. First-...
Previous clinical and basic studies have revealed that ginseng might have cardioprotective properties against anthracycline-induced cardiotoxicity (AIC). However, the underlying mechanism of ginseng a...
Fourteen drug-disease common targets were identified. Enrichment analysis showed that the AGE-RAGE in diabetic complications, fluid shear stress and atherosclerosis, and TNF signaling pathway were pot...
This study suggested that ginseng might exert their protective effects against AIC through the derived effector compounds beta-Sitosterol, Kaempferol and Fumarine by targeting CCNA2, STAT1, and ICAM1,...
Diabetes mellitus (DM) is a metabolic disorder disease that causes hyperglycemia conditions and associated with various chronic complications leading to mortality. Due to high toxicity of conventional...
Docking between ligand and FOXO1 receptor was carried out with Autodock4.2. For molecular dynamics simulations, the force fields of DNA.OL15, protein.ff14SB, gaff2, and tip3p were used....
During storage and processing, muscle proteins, e.g. myosin and myoglobin, will inevitably undergo degeneration, which is thus accompanied by quality deterioration of muscle foods. Some exogenous addi...
Cereblon (CRBN) is a substrate receptor of E3 ubiquitin ligase as well as the target of thalidomide and lenalidomide, plays a vital role in endogenous protein degradation. In this article, two series ...
Direct oral anticoagulants are an important and relatively new class of synthetic anticoagulant drugs commonly used for the pharmacotherapy of thromboembolic disorders. However, they still have some l...
Cancer is a serious threat to human life and social development and the use of scientific methods for cancer prevention and control is necessary. In this study, HQSAR, CoMFA, CoMSIA and TopomerCoMFA m...
The pandemic of COVID-19 caused by SARS-CoV-2 has made a worldwide health emergency. Despite the fact that current vaccines are readily available, several SARSCoV-2 variants affecting the existing vac...
Oritavancin is a semi-synthetic lipoglycopeptide antibiotic primarily used to treat serious infections caused by Gram-positive bacteria. The aim of this study was to elucidate possible molecular targe...
Computational methods were used in this study which include target prediction, molecular docking, molecular dynamics simulation, pharmacokinetics prediction, and physiological-based pharmacokinetics (...
Oritavancin was moderately soluble in water and did not permeate the blood-brain barrier. Seven molecular targets were identified in humans. Molecular docking results showed highest binding affinity o...
This comprehensive computational study has provided invaluable insights into the pharmacological profile of Oritavancin, aiding its further development and optimization for clinical use....